Trillium Therapeutics Inc. Gains 43.66%

Trillium Therapeutics Inc. (TRIL:NASDAQ) rocketted at $13.59, representing a gain of 43.7%. On Tue 08 Sep 20, TRIL:NASDAQ hit a New 2-Week Low of $9.46. The stock got featured on our News Catalysts scanner on Wed 09 Sep 20 at 04:09 PM in the 'PUBLIC OFFERING' category. From Tue 25 Aug 20, the stock recorded 33.33% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Trillium Therapeutics Inc. (TRIL:NASDAQ)

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.